Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-04

AUTHORS

Eduardo Tolosa, Basilio Hernández, Gurutz Linazasoro, Juan José López-Lozano, Pablo Mir, José Marey, Jaime Kulisevsky

ABSTRACT

To compare the efficacy and safety of levodopa/carbidopa/entacapone (LCE) with levodopa/carbidopa (LC) on Parkinson's disease (PD) patients with mild, or only minimally disabling motor complications. A prospective 3-month, multicentre, parallel-group, double-blind, and randomised phase IV study was performed. The primary endpoint was to assess the efficacy of LCE compared to LC on ADLs using the UPDRS part II. Secondary endpoints were assessed by the UPDRS (I, III and IV) scores, QUICK and PDQ-39 questionnaires, and patient and investigator clinical global impression (CGI). Ninety-five patients were randomly assigned to treatment with LCE (100/25/200 or 150/37.5/200 mg tablets, n = 46) or LC (100/25 mg tablets, n = 49), at the same levodopa dose that were administered before randomization. Treatment with LCE resulted in significantly greater improvement in UPDRS part II (ADLs) scores compared to treatment with LC (adjusted mean difference between groups of -1.5 points) (p = 0.0288). Amelioration was also observed in UPDRS part III scores (p = 0.010), and CGI (patient and investigator) scores (p = 0.015, and p = 0.028, respectively). LCE and LC were generally well tolerated with 78 % of subjects completing the study. Most AEs (50 % in LCE and 71.4 % in LC) were classified as mild. No serious AEs were related to the treatment. Treatment with LCE results in improved efficacy compared to LC in PD patients with mild, or minimally disabling motor fluctuations, maintaining a good safety and tolerability profile. More... »

PAGES

357-366

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00702-013-1114-x

DOI

http://dx.doi.org/10.1007/s00702-013-1114-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051913073

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24253234


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiparkinson Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carbidopa", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catechols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Levodopa", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitriles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parkinson Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Neurology Service, Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Cl\u00ednic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tolosa", 
        "givenName": "Eduardo", 
        "id": "sg:person.01223526364.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223526364.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Spain)", 
          "id": "https://www.grid.ac/institutes/grid.476612.0", 
          "name": [
            "Novartis Farmac\u00e9utica, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hern\u00e1ndez", 
        "givenName": "Basilio", 
        "id": "sg:person.01272414271.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272414271.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Policl\u00ednica Gipuzkoa", 
          "id": "https://www.grid.ac/institutes/grid.429915.2", 
          "name": [
            "Policl\u00ednica Gipuzkoa, San Sebasti\u00e1n, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Linazasoro", 
        "givenName": "Gurutz", 
        "id": "sg:person.01112432517.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112432517.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cl\u00ednica Ruber, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00f3pez-Lozano", 
        "givenName": "Juan Jos\u00e9", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas", 
          "id": "https://www.grid.ac/institutes/grid.418264.d", 
          "name": [
            "Hospital Virgen del Roc\u00edo, Sevilla, Spain", 
            "Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas CIBERNED, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mir", 
        "givenName": "Pablo", 
        "id": "sg:person.0731624314.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731624314.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Complexo Hospitalario Universitario A Coru\u00f1a", 
          "id": "https://www.grid.ac/institutes/grid.411066.4", 
          "name": [
            "Hospital Universitario A Coru\u00f1a, Coru\u00f1a, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marey", 
        "givenName": "Jos\u00e9", 
        "id": "sg:person.01335737351.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335737351.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital de Sant Pau", 
          "id": "https://www.grid.ac/institutes/grid.413396.a", 
          "name": [
            "Hospital de Sant Pau, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kulisevsky", 
        "givenName": "Jaime", 
        "id": "sg:person.01072147533.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072147533.02"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1474-4422(05)70098-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002094817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.21878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005397870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.22060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006797666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.22060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006797666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11055-008-9085-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009108105", 
          "https://doi.org/10.1007/s11055-008-9085-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ndt.s1660", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009563112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00702-009-0344-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009717272", 
          "https://doi.org/10.1007/s00702-009-0344-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00702-009-0344-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009717272", 
          "https://doi.org/10.1007/s00702-009-0344-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00702-009-0344-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009717272", 
          "https://doi.org/10.1007/s00702-009-0344-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0404.2004.00363.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020930180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-005-4008-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021271892", 
          "https://doi.org/10.1007/s00415-005-4008-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-005-4008-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021271892", 
          "https://doi.org/10.1007/s00415-005-4008-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.410420511", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022492500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/pl00007743", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024227110", 
          "https://doi.org/10.1007/pl00007743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000300647", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027693186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.22343", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033861982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ndt.s5190", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034374954"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jnnp.68.5.589", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034615669"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa033447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035458376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00702-004-0190-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039582368", 
          "https://doi.org/10.1007/s00702-004-0190-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.21944", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042236960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14656566.7.10.1399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042259014"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.1969.00480160015001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044673012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1468-1331.2003.00559.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053210192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.44.5.913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064372505"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.51.5.1309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064376871"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.51.5.1309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064376871"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.51.5.1309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064376871"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-04", 
    "datePublishedReg": "2014-04-01", 
    "description": "To compare the efficacy and safety of levodopa/carbidopa/entacapone (LCE) with levodopa/carbidopa (LC) on Parkinson's disease (PD) patients with mild, or only minimally disabling motor complications. A prospective 3-month, multicentre, parallel-group, double-blind, and randomised phase IV study was performed. The primary endpoint was to assess the efficacy of LCE compared to LC on ADLs using the UPDRS part II. Secondary endpoints were assessed by the UPDRS (I, III and IV) scores, QUICK and PDQ-39 questionnaires, and patient and investigator clinical global impression (CGI). Ninety-five patients were randomly assigned to treatment with LCE (100/25/200 or 150/37.5/200\u00a0mg tablets, n\u00a0=\u00a046) or LC (100/25\u00a0mg tablets, n\u00a0=\u00a049), at the same levodopa dose that were administered before randomization. Treatment with LCE resulted in significantly greater improvement in UPDRS part II (ADLs) scores compared to treatment with LC (adjusted mean difference between groups of -1.5 points) (p\u00a0=\u00a00.0288). Amelioration was also observed in UPDRS part III scores (p\u00a0=\u00a00.010), and CGI (patient and investigator) scores (p\u00a0=\u00a00.015, and p\u00a0=\u00a00.028, respectively). LCE and LC were generally well tolerated with 78\u00a0% of subjects completing the study. Most AEs (50\u00a0% in LCE and 71.4\u00a0% in LC) were classified as mild. No serious AEs were related to the treatment. Treatment with LCE results in improved efficacy compared to LC in PD patients with mild, or minimally disabling motor fluctuations, maintaining a good safety and tolerability profile. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00702-013-1114-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1312227", 
        "issn": [
          "0300-9564", 
          "1435-1463"
        ], 
        "name": "Journal of Neural Transmission", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "121"
      }
    ], 
    "name": "Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson\u2019s disease experiencing mild wearing-off: a randomised, double-blind trial", 
    "pagination": "357-366", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f7489de279ff8a3ebc02b1550bfe809511b4b8459f673d21122f2c430d3a8513"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24253234"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9702341"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00702-013-1114-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051913073"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00702-013-1114-x", 
      "https://app.dimensions.ai/details/publication/pub.1051913073"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8684_00000491.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00702-013-1114-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00702-013-1114-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00702-013-1114-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00702-013-1114-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00702-013-1114-x'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      21 PREDICATES      69 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00702-013-1114-x schema:about N00be545bcb784bb7b2202d619094bfc1
2 N0ccdac67926743b6a51dc5697c39c4a0
3 N111cfe8590f44a6596ec3806c4de3492
4 N2f91c6200b8741bc8ec4c17eae9bc9e3
5 N3c6ae62aacf5428693454466c2d169a8
6 N5661495282894f1cb2684123478f16c0
7 N5811aded94ba49d5a7ac24ce79534c79
8 N7a60cd42abfd44cc9ba7c0ce8377883d
9 N803877f49bd04229abd67c278d5fa0ca
10 N806832836995411e993265ce56fb555c
11 N86e99d1571524503a543994179645e8a
12 N96332c2396b44cd2901a4c6df317b06e
13 Na36d097bb9e2484fbc2130026e151ac6
14 Naa053f9215e34a5696fda18dece142be
15 Nca6b69ad41224090ab7910c6e3d52957
16 Ncaa7c0b1010f4d48938cbb68b5014977
17 Nd34a76169aef48e58d3d4214f03f56fd
18 Nfbd37d92206d406f82330cda107de475
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author Nb654384e8e504bcab0bbcbf4c8185328
22 schema:citation sg:pub.10.1007/pl00007743
23 sg:pub.10.1007/s00415-005-4008-5
24 sg:pub.10.1007/s00702-004-0190-3
25 sg:pub.10.1007/s00702-009-0344-4
26 sg:pub.10.1007/s11055-008-9085-3
27 https://doi.org/10.1001/archneur.1969.00480160015001
28 https://doi.org/10.1002/ana.22060
29 https://doi.org/10.1002/ana.410420511
30 https://doi.org/10.1002/mds.21878
31 https://doi.org/10.1002/mds.21944
32 https://doi.org/10.1002/mds.22343
33 https://doi.org/10.1016/s1474-4422(05)70098-3
34 https://doi.org/10.1046/j.1468-1331.2003.00559.x
35 https://doi.org/10.1056/nejmoa033447
36 https://doi.org/10.1111/j.1600-0404.2004.00363.x
37 https://doi.org/10.1136/jnnp.68.5.589
38 https://doi.org/10.1159/000300647
39 https://doi.org/10.1212/wnl.44.5.913
40 https://doi.org/10.1212/wnl.51.5.1309
41 https://doi.org/10.1517/14656566.7.10.1399
42 https://doi.org/10.2147/ndt.s1660
43 https://doi.org/10.2147/ndt.s5190
44 schema:datePublished 2014-04
45 schema:datePublishedReg 2014-04-01
46 schema:description To compare the efficacy and safety of levodopa/carbidopa/entacapone (LCE) with levodopa/carbidopa (LC) on Parkinson's disease (PD) patients with mild, or only minimally disabling motor complications. A prospective 3-month, multicentre, parallel-group, double-blind, and randomised phase IV study was performed. The primary endpoint was to assess the efficacy of LCE compared to LC on ADLs using the UPDRS part II. Secondary endpoints were assessed by the UPDRS (I, III and IV) scores, QUICK and PDQ-39 questionnaires, and patient and investigator clinical global impression (CGI). Ninety-five patients were randomly assigned to treatment with LCE (100/25/200 or 150/37.5/200 mg tablets, n = 46) or LC (100/25 mg tablets, n = 49), at the same levodopa dose that were administered before randomization. Treatment with LCE resulted in significantly greater improvement in UPDRS part II (ADLs) scores compared to treatment with LC (adjusted mean difference between groups of -1.5 points) (p = 0.0288). Amelioration was also observed in UPDRS part III scores (p = 0.010), and CGI (patient and investigator) scores (p = 0.015, and p = 0.028, respectively). LCE and LC were generally well tolerated with 78 % of subjects completing the study. Most AEs (50 % in LCE and 71.4 % in LC) were classified as mild. No serious AEs were related to the treatment. Treatment with LCE results in improved efficacy compared to LC in PD patients with mild, or minimally disabling motor fluctuations, maintaining a good safety and tolerability profile.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree false
50 schema:isPartOf N0cb463cf3bce4770a76ebea8c70216a4
51 N2b8835d379184d16bbf16ecd21d497b7
52 sg:journal.1312227
53 schema:name Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
54 schema:pagination 357-366
55 schema:productId N00c5f0544c7f4f34b4bb5c40b11763ea
56 N20e20a98131c4975898488fdf61a6e86
57 N59faf01f550544aa9505ae12c41b5ba9
58 Nca37253a8ea44d68955c40aa0186d569
59 Nd42ee66e6bc64100a733c9e8cb84f7fd
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051913073
61 https://doi.org/10.1007/s00702-013-1114-x
62 schema:sdDatePublished 2019-04-10T20:42
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N44b0e2f881894f64b7ca2aabaf3554d3
65 schema:url http://link.springer.com/10.1007/s00702-013-1114-x
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N00be545bcb784bb7b2202d619094bfc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Retrospective Studies
71 rdf:type schema:DefinedTerm
72 N00c5f0544c7f4f34b4bb5c40b11763ea schema:name nlm_unique_id
73 schema:value 9702341
74 rdf:type schema:PropertyValue
75 N0cb463cf3bce4770a76ebea8c70216a4 schema:volumeNumber 121
76 rdf:type schema:PublicationVolume
77 N0ccdac67926743b6a51dc5697c39c4a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Adult
79 rdf:type schema:DefinedTerm
80 N111cfe8590f44a6596ec3806c4de3492 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Double-Blind Method
82 rdf:type schema:DefinedTerm
83 N20e20a98131c4975898488fdf61a6e86 schema:name pubmed_id
84 schema:value 24253234
85 rdf:type schema:PropertyValue
86 N2b8835d379184d16bbf16ecd21d497b7 schema:issueNumber 4
87 rdf:type schema:PublicationIssue
88 N2f91c6200b8741bc8ec4c17eae9bc9e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Aged
90 rdf:type schema:DefinedTerm
91 N3359acd8eccb4ef790f695a83a9bb91d rdf:first N5e5080f77d8a44169005098d61704e83
92 rdf:rest Nb3256562a64d4a7ea1d78f25fddb5533
93 N3c6ae62aacf5428693454466c2d169a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Surveys and Questionnaires
95 rdf:type schema:DefinedTerm
96 N3f8792103a004de2814adad02aacd15c schema:name Clínica Ruber, Madrid, Spain
97 rdf:type schema:Organization
98 N44b0e2f881894f64b7ca2aabaf3554d3 schema:name Springer Nature - SN SciGraph project
99 rdf:type schema:Organization
100 N5661495282894f1cb2684123478f16c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Aged, 80 and over
102 rdf:type schema:DefinedTerm
103 N5811aded94ba49d5a7ac24ce79534c79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Antiparkinson Agents
105 rdf:type schema:DefinedTerm
106 N59faf01f550544aa9505ae12c41b5ba9 schema:name dimensions_id
107 schema:value pub.1051913073
108 rdf:type schema:PropertyValue
109 N5e5080f77d8a44169005098d61704e83 schema:affiliation N3f8792103a004de2814adad02aacd15c
110 schema:familyName López-Lozano
111 schema:givenName Juan José
112 rdf:type schema:Person
113 N7a60cd42abfd44cc9ba7c0ce8377883d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Nitriles
115 rdf:type schema:DefinedTerm
116 N7e8342ba1aa744bca66e01548b743e44 rdf:first sg:person.01272414271.19
117 rdf:rest Na35d69bc3a6e41a2b21e1ea3131dc9b2
118 N803877f49bd04229abd67c278d5fa0ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Female
120 rdf:type schema:DefinedTerm
121 N806832836995411e993265ce56fb555c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Middle Aged
123 rdf:type schema:DefinedTerm
124 N86e99d1571524503a543994179645e8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Catechols
126 rdf:type schema:DefinedTerm
127 N96332c2396b44cd2901a4c6df317b06e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Parkinson Disease
129 rdf:type schema:DefinedTerm
130 N97f4a503638a41fd9186f09fd4b3beef schema:name Neurology Service, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
131 rdf:type schema:Organization
132 Na35d69bc3a6e41a2b21e1ea3131dc9b2 rdf:first sg:person.01112432517.54
133 rdf:rest N3359acd8eccb4ef790f695a83a9bb91d
134 Na36d097bb9e2484fbc2130026e151ac6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Drug Therapy, Combination
136 rdf:type schema:DefinedTerm
137 Naa053f9215e34a5696fda18dece142be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Carbidopa
139 rdf:type schema:DefinedTerm
140 Nb3256562a64d4a7ea1d78f25fddb5533 rdf:first sg:person.0731624314.21
141 rdf:rest Nf420494f717b4f2abf77bdec8bdf7ef7
142 Nb654384e8e504bcab0bbcbf4c8185328 rdf:first sg:person.01223526364.47
143 rdf:rest N7e8342ba1aa744bca66e01548b743e44
144 Nca37253a8ea44d68955c40aa0186d569 schema:name doi
145 schema:value 10.1007/s00702-013-1114-x
146 rdf:type schema:PropertyValue
147 Nca6b69ad41224090ab7910c6e3d52957 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Male
149 rdf:type schema:DefinedTerm
150 Ncaa7c0b1010f4d48938cbb68b5014977 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Severity of Illness Index
152 rdf:type schema:DefinedTerm
153 Nd34a76169aef48e58d3d4214f03f56fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Levodopa
155 rdf:type schema:DefinedTerm
156 Nd42ee66e6bc64100a733c9e8cb84f7fd schema:name readcube_id
157 schema:value f7489de279ff8a3ebc02b1550bfe809511b4b8459f673d21122f2c430d3a8513
158 rdf:type schema:PropertyValue
159 Nf420494f717b4f2abf77bdec8bdf7ef7 rdf:first sg:person.01335737351.29
160 rdf:rest Nff27050b02e74e41a5984e029ab0127a
161 Nfbd37d92206d406f82330cda107de475 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Humans
163 rdf:type schema:DefinedTerm
164 Nff27050b02e74e41a5984e029ab0127a rdf:first sg:person.01072147533.02
165 rdf:rest rdf:nil
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
170 schema:name Clinical Sciences
171 rdf:type schema:DefinedTerm
172 sg:journal.1312227 schema:issn 0300-9564
173 1435-1463
174 schema:name Journal of Neural Transmission
175 rdf:type schema:Periodical
176 sg:person.01072147533.02 schema:affiliation https://www.grid.ac/institutes/grid.413396.a
177 schema:familyName Kulisevsky
178 schema:givenName Jaime
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072147533.02
180 rdf:type schema:Person
181 sg:person.01112432517.54 schema:affiliation https://www.grid.ac/institutes/grid.429915.2
182 schema:familyName Linazasoro
183 schema:givenName Gurutz
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112432517.54
185 rdf:type schema:Person
186 sg:person.01223526364.47 schema:affiliation N97f4a503638a41fd9186f09fd4b3beef
187 schema:familyName Tolosa
188 schema:givenName Eduardo
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223526364.47
190 rdf:type schema:Person
191 sg:person.01272414271.19 schema:affiliation https://www.grid.ac/institutes/grid.476612.0
192 schema:familyName Hernández
193 schema:givenName Basilio
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272414271.19
195 rdf:type schema:Person
196 sg:person.01335737351.29 schema:affiliation https://www.grid.ac/institutes/grid.411066.4
197 schema:familyName Marey
198 schema:givenName José
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335737351.29
200 rdf:type schema:Person
201 sg:person.0731624314.21 schema:affiliation https://www.grid.ac/institutes/grid.418264.d
202 schema:familyName Mir
203 schema:givenName Pablo
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731624314.21
205 rdf:type schema:Person
206 sg:pub.10.1007/pl00007743 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024227110
207 https://doi.org/10.1007/pl00007743
208 rdf:type schema:CreativeWork
209 sg:pub.10.1007/s00415-005-4008-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021271892
210 https://doi.org/10.1007/s00415-005-4008-5
211 rdf:type schema:CreativeWork
212 sg:pub.10.1007/s00702-004-0190-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039582368
213 https://doi.org/10.1007/s00702-004-0190-3
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/s00702-009-0344-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009717272
216 https://doi.org/10.1007/s00702-009-0344-4
217 rdf:type schema:CreativeWork
218 sg:pub.10.1007/s11055-008-9085-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009108105
219 https://doi.org/10.1007/s11055-008-9085-3
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1001/archneur.1969.00480160015001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044673012
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1002/ana.22060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006797666
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1002/ana.410420511 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022492500
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1002/mds.21878 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005397870
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1002/mds.21944 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042236960
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1002/mds.22343 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033861982
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/s1474-4422(05)70098-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002094817
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1046/j.1468-1331.2003.00559.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053210192
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1056/nejmoa033447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035458376
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1111/j.1600-0404.2004.00363.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1020930180
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1136/jnnp.68.5.589 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034615669
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1159/000300647 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027693186
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1212/wnl.44.5.913 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064372505
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1212/wnl.51.5.1309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064376871
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1517/14656566.7.10.1399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042259014
250 rdf:type schema:CreativeWork
251 https://doi.org/10.2147/ndt.s1660 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009563112
252 rdf:type schema:CreativeWork
253 https://doi.org/10.2147/ndt.s5190 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034374954
254 rdf:type schema:CreativeWork
255 https://www.grid.ac/institutes/grid.411066.4 schema:alternateName Complexo Hospitalario Universitario A Coruña
256 schema:name Hospital Universitario A Coruña, Coruña, Spain
257 rdf:type schema:Organization
258 https://www.grid.ac/institutes/grid.413396.a schema:alternateName Hospital de Sant Pau
259 schema:name Hospital de Sant Pau, Barcelona, Spain
260 rdf:type schema:Organization
261 https://www.grid.ac/institutes/grid.418264.d schema:alternateName Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
262 schema:name Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas CIBERNED, Barcelona, Spain
263 Hospital Virgen del Rocío, Sevilla, Spain
264 rdf:type schema:Organization
265 https://www.grid.ac/institutes/grid.429915.2 schema:alternateName Policlínica Gipuzkoa
266 schema:name Policlínica Gipuzkoa, San Sebastián, Spain
267 rdf:type schema:Organization
268 https://www.grid.ac/institutes/grid.476612.0 schema:alternateName Novartis (Spain)
269 schema:name Novartis Farmacéutica, Barcelona, Spain
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...